spectrotyper v4.0 software (agena bioscience)
agena bioscience is a verified supplier 
agena bioscience manufactures this product 
90
Structured Review
agena bioscience
spectrotyper v4.0 software
Spectrotyper V4.0 Software, supplied by agena bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/spectrotyper+v4%2E0+software/spectrotyper+v4+0+software/pm38195677-126-36-39
Average 90 stars, based on 1 article reviews
Spectrotyper V4.0 Software, supplied by agena bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/spectrotyper+v4%2E0+software/spectrotyper+v4+0+software/pm38195677-126-36-39
Average 90 stars, based on 1 article reviews
spectrotyper v4.0 software - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Polymerase Chain Reaction:Article Title: Polymorphism of formyl peptide receptor 1 (FPR1) reduces the therapeutic efficiency and antitumor immunity after neoadjuvant chemoradiotherapy (CCRT) treatment in locally advanced rectal cancer. Article Snippet: Immunosurveillance and immunoscavenging prompted by preoperative chemoradiotherapy (CCRT) may contribute to improve local control and increase survival outcomes for patients with locally advanced rectal cancer (LARC).. In this study, we investigated several genotypes of pattern recognition receptors (PRRs) and their impact on therapeutic efficacy in LARC patients treated with CCRT.. We found that homozygosis of formyl peptide receptor 1 (FPR1) (E346A/rs867228) was associated with reduced 5-year overall survival (OS) by Kaplan–Meier analysis (62% vs. 81%, p = 0.014) and multivariate analysis [hazard ratio (HR) = 3.383, 95% CI = 1.374–10.239, p = 0.007]. Article Title: Assessment of common somatic mutations of EGFR , KRAS , BRAF , NRAS in pulmonary non-small cell carcinoma using iPLEX ® HS, a new highly sensitive assay for the MassARRAY ® System Article Snippet: Following the PCR reaction, SAP addition, and iPLEX HS ® extension reaction, the samples were desalted by resin treatment for 15 min, spotted onto Article Title: Dysfunctional TLR1 reduces the therapeutic efficacy of chemotherapy by attenuating HMGB1-mediated antitumor immunity in locally advanced colorectal cancer Article Snippet: Following PCR, SAP addition, and the iPLEX HS® extension reaction, the samples were desalted by resin treatment for 15 min, spotted onto Article Title: TNFα modulates PANX1 activation to promote ATP release and enhance P2RX7-mediated antitumor immune responses after chemotherapy in colorectal cancer Article Snippet: Following PCR, SAP addition, and the iPLEX HS ® extension reaction, the samples were desalted by resin treatment for 15 min, spotted onto Article Title: Dysfunctional TLR1 reduces the therapeutic efficacy of chemotherapy by attenuating HMGB1-mediated antitumor immunity in locally advanced colorectal cancer. Article Snippet: Following PCR, SAP addition, and the iPLEX HS® extension reaction, the samples were desalted by resin treatment for 15 min, spotted onto Article Title: <p>Comprehensive Characterization of Stage IIIA Non-Small Cell Lung Carcinoma</p> Article Snippet: Mutation Genotyping by Mass Array System Mutation detection was performed in 18 LUAD and 20 LUSC stage IIIA NSCLC samples using the OncoFOCUS panel V1.0 (Includes various known hotspot mutations of EGFR, KRAS, NRAS, and BRAF) on the MassARRAY® System and Article Title: TNFα modulates PANX1 activation to promote ATP release and enhance P2RX7-mediated antitumor immune responses after chemotherapy in colorectal cancer. Article Snippet: Following PCR, SAP addition, and the iPLEX HS® extension reaction, the samples were desalted by resin treatment for 15min, spotted onto Article Title: Development and evaluation of ActSeq: A targeted next-generation sequencing panel for clinical oncology use Article Snippet: Mass Spectrometry:Article Title: Polymorphism of formyl peptide receptor 1 (FPR1) reduces the therapeutic efficiency and antitumor immunity after neoadjuvant chemoradiotherapy (CCRT) treatment in locally advanced rectal cancer. Article Snippet: Immunosurveillance and immunoscavenging prompted by preoperative chemoradiotherapy (CCRT) may contribute to improve local control and increase survival outcomes for patients with locally advanced rectal cancer (LARC).. In this study, we investigated several genotypes of pattern recognition receptors (PRRs) and their impact on therapeutic efficacy in LARC patients treated with CCRT.. We found that homozygosis of formyl peptide receptor 1 (FPR1) (E346A/rs867228) was associated with reduced 5-year overall survival (OS) by Kaplan–Meier analysis (62% vs. 81%, p = 0.014) and multivariate analysis [hazard ratio (HR) = 3.383, 95% CI = 1.374–10.239, p = 0.007]. Article Title: Assessment of common somatic mutations of EGFR , KRAS , BRAF , NRAS in pulmonary non-small cell carcinoma using iPLEX ® HS, a new highly sensitive assay for the MassARRAY ® System Article Snippet: Following the PCR reaction, SAP addition, and iPLEX HS ® extension reaction, the samples were desalted by resin treatment for 15 min, spotted onto Article Title: Dysfunctional TLR1 reduces the therapeutic efficacy of chemotherapy by attenuating HMGB1-mediated antitumor immunity in locally advanced colorectal cancer Article Snippet: Following PCR, SAP addition, and the iPLEX HS® extension reaction, the samples were desalted by resin treatment for 15 min, spotted onto Article Title: TNFα modulates PANX1 activation to promote ATP release and enhance P2RX7-mediated antitumor immune responses after chemotherapy in colorectal cancer Article Snippet: Following PCR, SAP addition, and the iPLEX HS ® extension reaction, the samples were desalted by resin treatment for 15 min, spotted onto Article Title: Dysfunctional TLR1 reduces the therapeutic efficacy of chemotherapy by attenuating HMGB1-mediated antitumor immunity in locally advanced colorectal cancer. Article Snippet: Following PCR, SAP addition, and the iPLEX HS® extension reaction, the samples were desalted by resin treatment for 15 min, spotted onto Article Title: <p>Comprehensive Characterization of Stage IIIA Non-Small Cell Lung Carcinoma</p> Article Snippet: Mutation Genotyping by Mass Array System Mutation detection was performed in 18 LUAD and 20 LUSC stage IIIA NSCLC samples using the OncoFOCUS panel V1.0 (Includes various known hotspot mutations of EGFR, KRAS, NRAS, and BRAF) on the MassARRAY® System and Article Title: TNFα modulates PANX1 activation to promote ATP release and enhance P2RX7-mediated antitumor immune responses after chemotherapy in colorectal cancer. Article Snippet: Following PCR, SAP addition, and the iPLEX HS® extension reaction, the samples were desalted by resin treatment for 15min, spotted onto Article Title: Development and evaluation of ActSeq: A targeted next-generation sequencing panel for clinical oncology use Article Snippet: Software:Article Title: Polymorphism of formyl peptide receptor 1 (FPR1) reduces the therapeutic efficiency and antitumor immunity after neoadjuvant chemoradiotherapy (CCRT) treatment in locally advanced rectal cancer. Article Snippet: Immunosurveillance and immunoscavenging prompted by preoperative chemoradiotherapy (CCRT) may contribute to improve local control and increase survival outcomes for patients with locally advanced rectal cancer (LARC).. In this study, we investigated several genotypes of pattern recognition receptors (PRRs) and their impact on therapeutic efficacy in LARC patients treated with CCRT.. We found that homozygosis of formyl peptide receptor 1 (FPR1) (E346A/rs867228) was associated with reduced 5-year overall survival (OS) by Kaplan–Meier analysis (62% vs. 81%, p = 0.014) and multivariate analysis [hazard ratio (HR) = 3.383, 95% CI = 1.374–10.239, p = 0.007]. Article Title: Assessment of common somatic mutations of EGFR , KRAS , BRAF , NRAS in pulmonary non-small cell carcinoma using iPLEX ® HS, a new highly sensitive assay for the MassARRAY ® System Article Snippet: Following the PCR reaction, SAP addition, and iPLEX HS ® extension reaction, the samples were desalted by resin treatment for 15 min, spotted onto Article Title: Dysfunctional TLR1 reduces the therapeutic efficacy of chemotherapy by attenuating HMGB1-mediated antitumor immunity in locally advanced colorectal cancer Article Snippet: Following PCR, SAP addition, and the iPLEX HS® extension reaction, the samples were desalted by resin treatment for 15 min, spotted onto Article Title: TNFα modulates PANX1 activation to promote ATP release and enhance P2RX7-mediated antitumor immune responses after chemotherapy in colorectal cancer Article Snippet: Following PCR, SAP addition, and the iPLEX HS ® extension reaction, the samples were desalted by resin treatment for 15 min, spotted onto Article Title: Dysfunctional TLR1 reduces the therapeutic efficacy of chemotherapy by attenuating HMGB1-mediated antitumor immunity in locally advanced colorectal cancer. Article Snippet: Following PCR, SAP addition, and the iPLEX HS® extension reaction, the samples were desalted by resin treatment for 15 min, spotted onto Article Title: <p>Comprehensive Characterization of Stage IIIA Non-Small Cell Lung Carcinoma</p> Article Snippet: Mutation Genotyping by Mass Array System Mutation detection was performed in 18 LUAD and 20 LUSC stage IIIA NSCLC samples using the OncoFOCUS panel V1.0 (Includes various known hotspot mutations of EGFR, KRAS, NRAS, and BRAF) on the MassARRAY® System and Article Title: TNFα modulates PANX1 activation to promote ATP release and enhance P2RX7-mediated antitumor immune responses after chemotherapy in colorectal cancer. Article Snippet: Following PCR, SAP addition, and the iPLEX HS® extension reaction, the samples were desalted by resin treatment for 15min, spotted onto Article Title: Development and evaluation of ActSeq: A targeted next-generation sequencing panel for clinical oncology use Article Snippet: Mutagenesis:Article Title: Polymorphism of formyl peptide receptor 1 (FPR1) reduces the therapeutic efficiency and antitumor immunity after neoadjuvant chemoradiotherapy (CCRT) treatment in locally advanced rectal cancer. Article Snippet: Immunosurveillance and immunoscavenging prompted by preoperative chemoradiotherapy (CCRT) may contribute to improve local control and increase survival outcomes for patients with locally advanced rectal cancer (LARC).. In this study, we investigated several genotypes of pattern recognition receptors (PRRs) and their impact on therapeutic efficacy in LARC patients treated with CCRT.. We found that homozygosis of formyl peptide receptor 1 (FPR1) (E346A/rs867228) was associated with reduced 5-year overall survival (OS) by Kaplan–Meier analysis (62% vs. 81%, p = 0.014) and multivariate analysis [hazard ratio (HR) = 3.383, 95% CI = 1.374–10.239, p = 0.007]. Article Title: Assessment of common somatic mutations of EGFR , KRAS , BRAF , NRAS in pulmonary non-small cell carcinoma using iPLEX ® HS, a new highly sensitive assay for the MassARRAY ® System Article Snippet: Following the PCR reaction, SAP addition, and iPLEX HS ® extension reaction, the samples were desalted by resin treatment for 15 min, spotted onto Article Title: Dysfunctional TLR1 reduces the therapeutic efficacy of chemotherapy by attenuating HMGB1-mediated antitumor immunity in locally advanced colorectal cancer Article Snippet: Following PCR, SAP addition, and the iPLEX HS® extension reaction, the samples were desalted by resin treatment for 15 min, spotted onto Article Title: TNFα modulates PANX1 activation to promote ATP release and enhance P2RX7-mediated antitumor immune responses after chemotherapy in colorectal cancer Article Snippet: Following PCR, SAP addition, and the iPLEX HS ® extension reaction, the samples were desalted by resin treatment for 15 min, spotted onto Article Title: Dysfunctional TLR1 reduces the therapeutic efficacy of chemotherapy by attenuating HMGB1-mediated antitumor immunity in locally advanced colorectal cancer. Article Snippet: Following PCR, SAP addition, and the iPLEX HS® extension reaction, the samples were desalted by resin treatment for 15 min, spotted onto Article Title: <p>Comprehensive Characterization of Stage IIIA Non-Small Cell Lung Carcinoma</p> Article Snippet: Mutation Genotyping by Mass Array System Mutation detection was performed in 18 LUAD and 20 LUSC stage IIIA NSCLC samples using the OncoFOCUS panel V1.0 (Includes various known hotspot mutations of EGFR, KRAS, NRAS, and BRAF) on the MassARRAY® System and Article Title: TNFα modulates PANX1 activation to promote ATP release and enhance P2RX7-mediated antitumor immune responses after chemotherapy in colorectal cancer. Article Snippet: Following PCR, SAP addition, and the iPLEX HS® extension reaction, the samples were desalted by resin treatment for 15min, spotted onto Article Title: Development and evaluation of ActSeq: A targeted next-generation sequencing panel for clinical oncology use Article Snippet: Amplification:Article Title: Polymorphism of formyl peptide receptor 1 (FPR1) reduces the therapeutic efficiency and antitumor immunity after neoadjuvant chemoradiotherapy (CCRT) treatment in locally advanced rectal cancer. Article Snippet: Immunosurveillance and immunoscavenging prompted by preoperative chemoradiotherapy (CCRT) may contribute to improve local control and increase survival outcomes for patients with locally advanced rectal cancer (LARC).. In this study, we investigated several genotypes of pattern recognition receptors (PRRs) and their impact on therapeutic efficacy in LARC patients treated with CCRT.. We found that homozygosis of formyl peptide receptor 1 (FPR1) (E346A/rs867228) was associated with reduced 5-year overall survival (OS) by Kaplan–Meier analysis (62% vs. 81%, p = 0.014) and multivariate analysis [hazard ratio (HR) = 3.383, 95% CI = 1.374–10.239, p = 0.007]. Article Title: Assessment of common somatic mutations of EGFR , KRAS , BRAF , NRAS in pulmonary non-small cell carcinoma using iPLEX ® HS, a new highly sensitive assay for the MassARRAY ® System Article Snippet: Following the PCR reaction, SAP addition, and iPLEX HS ® extension reaction, the samples were desalted by resin treatment for 15 min, spotted onto Article Title: Dysfunctional TLR1 reduces the therapeutic efficacy of chemotherapy by attenuating HMGB1-mediated antitumor immunity in locally advanced colorectal cancer Article Snippet: Following PCR, SAP addition, and the iPLEX HS® extension reaction, the samples were desalted by resin treatment for 15 min, spotted onto Article Title: TNFα modulates PANX1 activation to promote ATP release and enhance P2RX7-mediated antitumor immune responses after chemotherapy in colorectal cancer Article Snippet: Following PCR, SAP addition, and the iPLEX HS ® extension reaction, the samples were desalted by resin treatment for 15 min, spotted onto Article Title: Dysfunctional TLR1 reduces the therapeutic efficacy of chemotherapy by attenuating HMGB1-mediated antitumor immunity in locally advanced colorectal cancer. Article Snippet: Following PCR, SAP addition, and the iPLEX HS® extension reaction, the samples were desalted by resin treatment for 15 min, spotted onto Article Title: <p>Comprehensive Characterization of Stage IIIA Non-Small Cell Lung Carcinoma</p> Article Snippet: Mutation Genotyping by Mass Array System Mutation detection was performed in 18 LUAD and 20 LUSC stage IIIA NSCLC samples using the OncoFOCUS panel V1.0 (Includes various known hotspot mutations of EGFR, KRAS, NRAS, and BRAF) on the MassARRAY® System and Article Title: TNFα modulates PANX1 activation to promote ATP release and enhance P2RX7-mediated antitumor immune responses after chemotherapy in colorectal cancer. Article Snippet: Following PCR, SAP addition, and the iPLEX HS® extension reaction, the samples were desalted by resin treatment for 15min, spotted onto Article Title: Development and evaluation of ActSeq: A targeted next-generation sequencing panel for clinical oncology use Article Snippet: |